Quimi Daphne 4
4 · Century Therapeutics, Inc. · Filed Oct 3, 2022
Insider Transaction Report
Form 4
Quimi Daphne
Director
Transactions
- Award
Stock Option (right to buy)
2022-10-01+39,744→ 39,744 totalExercise: $9.89Exp: 2032-10-01→ Common Stock (39,744 underlying)
Footnotes (1)
- [F1]Century Therapeutics, Inc. (the "Company") issued Ms. Quimi stock options (the "Options") in connection with her appointment as a director. The Options vest in equal monthly installments over 36 months subject to Ms. Quimi's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan.